Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness

Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness

The reduction of the number of lumbar punctures performed during the follow-up of patients affected by sleeping sickness (HAT) is considered a research priority. Follow-up, consisting of the examination of cerebrospinal fluid (CSF) for presence of parasites and for the number of leukocytes, is neces...

Full description

Bibliographic Details
Main Authors: Tiberti, Natalia, Lejon, Veerle, Hainard, Alexandre, Courtioux, Bertrand, Robin, Xavier, Turck, Natacha, Kristensson, Krister, Matovu, Enock, Enyaru, John Charles, Mumba Ngoyi, Dieudonné, Krishna, Sanjeev, Bisser, Sylvie, Ndung′u, Joseph Mathu, Büscher, Philippe, Sanchez, Jean-Charles
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585011/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585011/

Similar Items